2m 2m 2m 2m 2m 2m 2m
Codexis (CDXS)
NASDAQ
$1.31+$0.02 (+1.47%)
Price as of Oct 22, 2026 7:30 PM EDT- $141.3MMarket Cap
- -49.61%1-Year Change
- BiotechnologyIndustry
Codexis (CDXS)
$1.31+$0.02 (+1.47%)
CDXS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.29 | ||
Change | +$0.06 (+4.88%) | ||
Open | $1.24 | ||
High | $1.31 | ||
Low | $1.23 | ||
Previous Close | $1.23 | ||
Volume | 1,058,060 | ||
30-Day Average Volume | 824,723 | ||
1-Week Change | 0.00% | ||
1-Month Change | -6.52% | ||
1-Year Change | -49.61% | ||
3-Year Change | -24.12% | ||
5-Year Change | -95.51% | ||
Fundamentals | |||
Shares Outstanding | 109.5M | ||
Total Assets | $120.1M | ||
Market Cap | $141.3M | ||
Enterprise Value | $155.0M | ||
Period: QTR TTM FY | |||
Revenue | $13.2M | ||
Net Income | -$12.0M | ||
Free Cash Flow | -$10.5M | ||
EBIT | -$10.7M | ||
EBITDA | -$9.5M | ||
Net Working Capital | $48.4M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 4 | ||
P/E | -10 | ||
PEG | 0 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue